Doug Bakan, PhD
Vice President, Product Development
Dr. Bakan joined Novalar in May 2008 as Vice President, Product Development.
brings more than 20 years experience in the discovery, development, commercialization and licensing of novel pharmaceutical products and medical technologies.
Immediately prior to joining Novalar, he served as Senior Director of Development at Neurocrine Biosciences where his team was responsible for program management of the company's diverse product pipeline aimed at treating diseases of the neurological and endocrine systems.
He has also served as Vice President of Business Development at Alerion Biomedical, a company that developed and launched the Fenestra™ line of in vivo imaging agents for CT and microCT imaging; Chief Operating Officer at MetaProbe LLC,; Director of Pharmaceutical Formulations and Manufacturing at Corvas International; and Associate Director of Product Development at Molecular Biosystems, Inc.
Dr. Bakan is an author or co-author on more than 50 peer reviewed publications and abstracts, is an inventor on 5 issued and numerous pending patent applications, and has won several awards in the field of in vivo medical imaging.
Dr. Bakan earned his BS in bioengineering and his PhD in biochemistry and physiology from the University of California, San Diego and completed post-doctoral work in the Department of Pharmacology at the University of Michigan.